FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Ascend Laboratories Fosfomycin Tromethamine Granules for Oral Recall

Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, M…

Ascend Laboratories, LLC · Parsippany, NJ

Risk level
Class III
Reported by FDA
Sep 13, 2023
Recall ID
D-1145-2023
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Fosfomycin Tromethamine Granules for Oral starting Jul 18, 2023. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1145-2023 on Sep 13, 2023. Reason: Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.

Product description

Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57

Lot numbers, UPCs & expiration codes

Lot #22121970, 22122158, 22121971, 22122189, 22122190, 22122277, 22122278, Exp June 2024; 22122521, 22122522, 22122523, Exp July 2024; 22123328, 22123329, 22123330, Exp September 2024.

Where it was sold

The recall product was distributed nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1145-2023
Classification
Class III
Status
Terminated
Recall initiated
Jul 18, 2023
FDA report date
Sep 13, 2023
Quantity
99,516 sachets
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-1145-2023, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
92706
Address
339 Jefferson Rd Ste 101
Code information
Lot #22121970, 22122158, 22121971, 22122189, 22122190, 22122277, 22122278, Exp June 2024; 22122521, 22122522, 22122523, Exp July 2024; 22123328, 22123329, 22123330, Exp September 2024.
Postal code
07054-3707
Report date
Sep 13, 2023
Product type
Drugs
Recall number
D-1145-2023
Classification
Class III
Recalling firm
Ascend Laboratories, LLC
Product quantity
99,516 sachets
Termination date
Feb 19, 2026
Reason for recall
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC# 67877-749-57
Distribution pattern
The recall product was distributed nationwide.
Recall initiation date
Jul 18, 2023
Initial firm notification
Letter
Center classification date
Sep 6, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1145-2023, published Sep 13, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls